Recent data also demonstrate the promising approach of pharmacological inhibition of the Menin-MLL (mixed-lineage leukemia 1-) complex in AML cells with both NPM1 mutation and FLT3 mutation. Here, KMT2A is linked to acute myeloid leukemia.